← Back to Clinical Trials
Recruiting NCT04921501

NCT04921501 Evaluation of Electrocardiographic Measurements by High Density Electrode ECG

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04921501
Status Recruiting
Phase
Sponsor University Hospital, Bordeaux
Condition Ventricular Arrhythmias
Study Type INTERVENTIONAL
Enrollment 1,800 participants
Start Date 2021-04-06
Primary Completion 2027-04

Trial Parameters

Condition Ventricular Arrhythmias
Sponsor University Hospital, Bordeaux
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,800
Sex ALL
Min Age 14 Years
Max Age N/A
Start Date 2021-04-06
Completion 2027-04
Interventions
HD ECGConventional 12-lead ECG

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cardiac electrical activity is detected on the body surface with conventional electrocardiography involving 12 leads (ECG 12). A limitation of the current ECG technique is that recordings are obtained from only 6 independent precordial leads pairs ; which may miss cardiac potentials from spatially limited regions. More extensive sampling of the body surface may contribute to additional clinical information. The present study investigates the additional sensitivity of ECG using 128 body surface leads (High Density (HD) ECG) in measuring global or regional cardiac activity.

Eligibility Criteria

Inclusion Criteria: * Patient managed at the Bordeaux University Hospital for assessment of documented severe ventricular arrhythmia (VF, sudden resuscitated death) or suspected (syncope, family history of sudden death, ECG or Holter abnormality) or impaired ventricular conduction, OR * Patients managed for prophylactic ventricular defibrillator implantation, according to international recommendations: Heart disease with ejection fraction \< 35%, heart disease with sustained ventricular tachycardia, cardiomyopathies with high rhythmic risk, * Women of childbearing age with effective contraception. Exclusion Criteria: * patients under 14 years old, * pregnant or nursing woman.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology